1. 〈http://www.who.int/medicines/services/counterfeit/impact/ImpactF_S/en/〉
2. Expert committee on specifications for pharmaceutical preparations, forty-third report;WHO;WHO Tech Rep Ser,2009
3. US Food and Drug Administration. Tamper-evident packaging requirements for over-the-counter (OTC) human drug products. CFR—code of federal regulations title 21 food and drugs. Part 211 Subpart G, Section 211.132; 2011.
4. US Food and Drug Administration. What is the status of electronic track and trace across the drug supply chain? FDA counterfeit drug task force reports 2006, section IV; 2006.
5. Burhouse R. How new packaging technologies are helping in the struggle against counterfeit drugs. Pharmaceutical manufacturing magazine; August 2010.